US Broker Ratings

Corcept Therapeutics Incorporat (CORT) Growth Potential: Biotech Powerhouse with a 23.81% Upside

Investors with a keen eye on the healthcare sector might find Corcept Therapeutics Incorporat (NASDAQ: CORT) an intriguing proposition. With a robust market cap of $12.31..

BrightSpring Health Services, I (BTSG) Stock Analysis: A 32.76% Upside Potential Amid Strong Buy Ratings

BrightSpring Health Services, I (BTSG), a major player in the healthcare sector, is garnering significant attention from investors thanks to its robust growth prospects and unanimous..

Madrigal Pharmaceuticals, Inc. (MDGL) Stock Analysis: A 27% Upside Potential Amid Biotech Innovation

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a prominent player in the biotechnology sector, is making waves with its innovative approach to tackling metabolic dysfunction-associated steatohepatitis (MASH). With..

Glaukos Corporation (GKOS) Growth Potential: A Healthcare Innovator with a 9.61% Upside

As a pioneering force in the medical devices industry, Glaukos Corporation (NYSE: GKOS) stands at the intersection of innovation and healthcare. With its cutting-edge therapies targeting..

Vaxcyte, Inc. (PCVX) Investor Outlook: Biotech Stock with an 82% Potential Upside

Investors looking for opportunities in the biotechnology sector should consider Vaxcyte, Inc. (PCVX), a clinical-stage vaccine innovation company that has garnered significant attention for its promising..

The Cooper Companies, Inc. (COO) Stock Analysis: Healthcare Giant with 14.51% Potential Upside

Investors keeping a keen eye on the healthcare sector may find The Cooper Companies, Inc. (NYSE: COO) an intriguing proposition. With a rich history dating back..

Jazz Pharmaceuticals (JAZZ) Stock Analysis: A 17% Upside Potential Lights Up Investor Interest

Jazz Pharmaceuticals plc (NASDAQ: JAZZ), a prominent player in the biotechnology sector, stands out in the healthcare industry with its innovative pharmaceutical offerings. Based in Dublin,..

Telix Pharmaceuticals Limited (TLX) Stock Analysis: Unpacking an 87.68% Potential Upside

Telix Pharmaceuticals Limited (ASX: TLX) presents an intriguing opportunity in the biotechnology space, especially for investors seeking exposure to the promising field of radiopharmaceuticals. With a..

Inspire Medical Systems, Inc. (INSP): Investor Outlook on Growth Prospects Amid Market Volatility

Inspire Medical Systems, Inc. (NYSE: INSP) stands at the intersection of technology and healthcare innovation, offering investors a unique opportunity to tap into the burgeoning medical..

Krystal Biotech, Inc. (KRYS) Stock Analysis: Strong Buy Ratings and 9.54% Potential Upside

Krystal Biotech, Inc. (NASDAQ: KRYS), a prominent player in the biotechnology sector, has captured the attention of investors with its promising pipeline of genetic medicines and..

Oscar Health, Inc. (OSCR) Stock Analysis: Is the Recent 70.4% Revenue Growth a Sign of More to Come?

Oscar Health, Inc. (NYSE: OSCR), a dynamic player in the healthcare technology sector, has caught the eye of investors with its notable 70.4% revenue growth. This..

Nuvalent, Inc. (NUVL) Stock Analysis: Exploring the Biotech’s Steady Path with a $9.81 Billion Market Cap

Nuvalent, Inc. (NASDAQ: NUVL), a clinical-stage biopharmaceutical company headquartered in Cambridge, Massachusetts, is making waves in the biotechnology sector with a market capitalization of $9.81 billion...

Option Care Health, Inc. (OPCH) Stock Analysis: Exploring a 19.6% Potential Upside in Healthcare Services

Option Care Health, Inc. (NASDAQ: OPCH) stands out in the healthcare sector, particularly within the medical care facilities industry, offering a diverse range of infusion services..

Axsome Therapeutics, Inc. (AXSM) Stock Analysis: A Biotech Gem with 43% Upside Potential

Axsome Therapeutics, Inc. (NASDAQ: AXSM) is capturing the attention of investors with its promising outlook in the biotechnology sector. As a company focused on developing innovative..

Solventum Corporation (SOLV) Stock Analysis: Understanding the Healthcare Giant’s 3.08% Potential Upside

In the world of healthcare investments, Solventum Corporation (SOLV) stands out as a promising player commanding a market capitalization of $15.51 billion. Specializing in medical instruments..

Rhythm Pharmaceuticals (RYTM): Investor Outlook on a 30.81% Potential Upside in Biotechnology

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM), a prominent player in the biopharmaceutical sector, offers a compelling investment opportunity for those interested in the rapidly evolving landscape of..

Viatris Inc. (VTRS) Stock Analysis: Exploring Its 13% Upside Potential and Dividend Appeal

Viatris Inc. (NASDAQ: VTRS) stands as a formidable player in the healthcare sector, particularly in the drug manufacturing industry, where it specializes in both specialty and..

Novartis AG (NVS): Investor Outlook on a Healthcare Giant with Promising Upside

Novartis AG (NYSE: NVS), a Swiss-based titan in the healthcare sector, has long been a stalwart in the pharmaceutical industry. With a robust market capitalization of..

Integer Holdings Corporation (ITGR) Stock Analysis: Navigating a Challenging Market with Strategic Insights

Integer Holdings Corporation (NYSE: ITGR), a prominent player in the healthcare sector, specializes in the manufacturing of medical devices, catering to a diverse range of medical..

TransMedics Group, Inc. (TMDX) Investor Outlook: Harnessing a 10% Upside Potential in Medical Devices

TransMedics Group, Inc. (NASDAQ: TMDX), a trailblazer in the healthcare sector, is making waves with its innovative approach to organ transplant therapy. Known for its Organ..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds